Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
Globe Newswire•25/08/2026•07:00 ET
0
Whiz Insights
Beyond Air to receive shares representing 19.99% of Univo's issued and outstanding share capital upon closing
Beyond Air eligible to receive up to $32.5 million in development and commercial milestone payments
Get started
Create a free account to read the full story.